Today’s trial update for MED2002 (topical treatment for erectile dysfunction, ED) is very encouraging, indicating that recruitment is on target and that no serious adverse events have been reported to date. Patient recruitment from additional EU sites is expected to commence in early 2016, subject to regulatory approval. We remain positive on MED2002, which can potentially be used to treat all men with ED, including the significant proportion (c. 7.5%) of sufferers who cannot be prescribed silde ....
17 Nov 2015
Erectile dysfunction trial on track
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Erectile dysfunction trial on track
Futura Medical plc (FUM:LON) | 36.0 0 0.0% | Mkt Cap: 108.4m
- Published:
17 Nov 2015 -
Author:
Dr Jens Lindqvist -
Pages:
3
Today’s trial update for MED2002 (topical treatment for erectile dysfunction, ED) is very encouraging, indicating that recruitment is on target and that no serious adverse events have been reported to date. Patient recruitment from additional EU sites is expected to commence in early 2016, subject to regulatory approval. We remain positive on MED2002, which can potentially be used to treat all men with ED, including the significant proportion (c. 7.5%) of sufferers who cannot be prescribed silde ....